Correlation Between Virax Biolabs and Rapport Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Virax Biolabs and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Rapport Therapeutics,.
Diversification Opportunities for Virax Biolabs and Rapport Therapeutics,
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Virax and Rapport is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Rapport Therapeutics, go up and down completely randomly.
Pair Corralation between Virax Biolabs and Rapport Therapeutics,
Given the investment horizon of 90 days Virax Biolabs is expected to generate 1.41 times less return on investment than Rapport Therapeutics,. In addition to that, Virax Biolabs is 1.85 times more volatile than Rapport Therapeutics, Common. It trades about 0.02 of its total potential returns per unit of risk. Rapport Therapeutics, Common is currently generating about 0.05 per unit of volatility. If you would invest 2,080 in Rapport Therapeutics, Common on September 4, 2024 and sell it today you would earn a total of 320.00 from holding Rapport Therapeutics, Common or generate 15.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 26.11% |
| Values | Daily Returns |
Virax Biolabs Group vs. Rapport Therapeutics, Common
Performance |
| Timeline |
| Virax Biolabs Group |
| Rapport Therapeutics, |
Virax Biolabs and Rapport Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Rapport Therapeutics,
The main advantage of trading using opposite Virax Biolabs and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Rapport Therapeutics, vs. Cars Inc | Rapport Therapeutics, vs. Amkor Technology | Rapport Therapeutics, vs. Wabash National | Rapport Therapeutics, vs. Marine Products |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stocks Directory Find actively traded stocks across global markets |